InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Bonner Michael, Chief Financial Officer. Director active across 1 company, notably Cumberland Pharmaceuticals INC. Cumulatively, 2 disclosures have been logged. Activity tracked since 17 March 2021. The latest transaction was disclosed on 17 March 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
1,067 shares@ US$3.220.0035% mcap100.0% of flowCommon StockSEC:0001209191-21-039917
1,067 shares@ US$3.220.0035% mcap50.0% of flowCommon StockSEC:0001209191-21-039917:0
2 of 2 declarations
About Bonner Michael
Michael Bonner is the Chief Financial Officer at CUMBERLAND PHARMACEUTICALS INC. He oversees the financial operations of the company, ensuring resource management and financial compliance. His role is essential for the financial health of the organization.
